Peptides · 10 min

Semaglutide (GLP-1)

Weight loss. Clinically proven.

Semaglutide is an FDA-approved GLP-1 receptor agonist that regulates appetite and blood sugar — clinically proven to support significant and sustained weight reduction. Administered as a weekly subcutaneous injection with medical oversight.

Benefits

• Clinically proven to reduce body weight by 10–15% on average
• Regulates appetite and reduces cravings
• Improves blood sugar control and cardiovascular markers

Consultation required